Cingulate Receives Complete Response Letter from FDA for CTx-1301
Cingulate Inc. No Clinical Safety or Efficacy Concerns Currently Identified Agency Feedback Primarily Focused on CMC-Related RequestsCompany Plans Prompt…
Browsing Tag
Cingulate Inc.
1 post